Jon A. Van Loon

2.1k total citations · 1 hit paper
24 papers, 1.6k citations indexed

About

Jon A. Van Loon is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Molecular Biology. According to data from OpenAlex, Jon A. Van Loon has authored 24 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Jon A. Van Loon's work include Acute Lymphoblastic Leukemia research (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Analytical Chemistry and Chromatography (4 papers). Jon A. Van Loon is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Analytical Chemistry and Chromatography (4 papers). Jon A. Van Loon collaborates with scholars based in United States, Netherlands and United Kingdom. Jon A. Van Loon's co-authors include Lynne Lennard, Richard M. Weinshilboum, Richard M. Weinshilboum, John Lilleyman, Diane M. Otterness, R. M. Weinshilboum, Thomas C. Wood, Rebecca B. Raftogianis, Norman R.C. Campbell and B. Maidak and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Genetics and Biochemical and Biophysical Research Communications.

In The Last Decade

Jon A. Van Loon

24 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism

1989 438 citations Lynne Lennard, Jon A. Van Loon et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon A. Van Loon United States	17	611	587	425	323	276	24	1.6k
Jarle Aarbakke Norway	25	602 1.0×	825 1.4×	274 0.6×	466 1.4×	147 0.5×	111	2.0k
C. L. Szumlanski United States	9	321 0.5×	403 0.7×	115 0.3×	196 0.6×	129 0.5×	13	864
Elaina Collie–Duguid United Kingdom	25	956 1.6×	424 0.7×	164 0.4×	241 0.7×	180 0.7×	37	2.1k
Dennis C. Mays United States	21	396 0.6×	274 0.5×	160 0.4×	98 0.3×	403 1.5×	56	1.4k
Javier G. Blanco United States	24	600 1.0×	438 0.7×	150 0.4×	420 1.3×	138 0.5×	75	1.8k
Christelle Cauffiez France	23	720 1.2×	123 0.2×	295 0.7×	174 0.5×	100 0.4×	60	1.5k
Poonkuzhali Balasubramanian India	26	1.2k 2.0×	464 0.8×	118 0.3×	208 0.6×	120 0.4×	137	2.4k
Edmund J.D. Lee Singapore	26	577 0.9×	142 0.2×	583 1.4×	540 1.7×	294 1.1×	45	2.0k
Katsuya Endo Japan	29	796 1.3×	132 0.2×	291 0.7×	45 0.1×	437 1.6×	128	2.2k
S.L. Hsia United States	27	538 0.9×	111 0.2×	253 0.6×	82 0.3×	167 0.6×	104	2.2k

Countries citing papers authored by Jon A. Van Loon

Since Specialization

Citations

This map shows the geographic impact of Jon A. Van Loon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon A. Van Loon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon A. Van Loon more than expected).

Fields of papers citing papers by Jon A. Van Loon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon A. Van Loon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon A. Van Loon. The network helps show where Jon A. Van Loon may publish in the future.

Co-authorship network of co-authors of Jon A. Van Loon

This figure shows the co-authorship network connecting the top 25 collaborators of Jon A. Van Loon. A scholar is included among the top collaborators of Jon A. Van Loon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon A. Van Loon. Jon A. Van Loon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eckel, Laurence J., et al.. (2020). Horner Syndrome Due To Internal Carotid Artery Dissection With Normal Vascular Imaging: A Radiological Conundrum. Journal of Neuro-Ophthalmology. 41(2). e186–e188. 2 indexed citations

Krahn, Lois E., et al.. (1998). A Schizophrenic Patient's Attempt to Resume Dialysis Following Renal Transplantation. Psychosomatics. 39(5). 470–473. 14 indexed citations

Raftogianis, Rebecca B., Thomas C. Wood, Diane M. Otterness, Jon A. Van Loon, & R. M. Weinshilboum. (1997). Phenol Sulfotransferase Pharmacogenetics in Humans: Association of CommonSULT1A1Alleles with TS PST Phenotype. Biochemical and Biophysical Research Communications. 239(1). 298–304. 243 indexed citations

Carvalho, Graça Simões de, et al.. (1996). Inhibition and stimulation of enzymatic activities of human fibroblasts by corrosion products and metal salts. Journal of Materials Science Materials in Medicine. 7(2). 77–83. 9 indexed citations

Loon, Jon A. Van, Carol L. Szumlanski, & Richard M. Weinshilboum. (1992). Human kidney thiopurine methyltransferase. Biochemical Pharmacology. 44(4). 775–785. 24 indexed citations

Hernández, Joaquim, Jon A. Van Loon, Diane M. Otterness, Roberto Guerciolini, & Richard M. Weinshilboum. (1991). Thiopurine methyltransferase regulation in rat kidney: Immunoprecipitation studies. Xenobiotica. 21(4). 451–459. 5 indexed citations

Hernández, Joaquim, Jon A. Van Loon, Diane M. Otterness, & Richard M. Weinshilboum. (1990). Mouse thiopurine methyltransferase pharmacogenetics: correlation of immunoreactive protein and enzymatic activity.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 568–573. 14 indexed citations

Loon, Jon A. Van, et al.. (1989). Sulfation pharmacogenetics: Correlation of human platelet and small intestinal phenol sulfotransferase. Clinical Pharmacology & Therapeutics. 46(5). 501–509. 23 indexed citations

Price, R. Arlen, et al.. (1989). Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity.. Genetics. 122(4). 905–914. 60 indexed citations

10.

Lennard, Lynne, Jon A. Van Loon, & Richard M. Weinshilboum. (1989). Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism. Clinical Pharmacology & Therapeutics. 46(2). 149–154. 438 indexed citations breakdown →

11.

Szumlanski, C. L., et al.. (1989). Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form.. Drug Metabolism and Disposition. 17(3). 255–264. 67 indexed citations

12.

Scott, Mary C., Jon A. Van Loon, & Richard M. Weinshilboum. (1988). Pharmacogenetics of N-methylation: Heritability of human erythrocyte histamine N-methyltransferase activity. Clinical Pharmacology & Therapeutics. 43(3). 256–262. 38 indexed citations

13.

Price, R. Arlen, Nancy J. Cox, Richard S. Spielman, et al.. (1988). Inheritance of human platelet thermolabile phenol sulfotransferase (TL PST) activity. Genetic Epidemiology. 5(1). 1–15. 43 indexed citations

14.

Campbell, Norm R.C., et al.. (1987). Human and rat liver phenol sulfotransferase: structure-activity relationships for phenolic substrates.. Molecular Pharmacology. 32(6). 813–819. 41 indexed citations

15.

Lennard, Lynne, Jon A. Van Loon, John Lilleyman, & Richard M. Weinshilboum. (1987). Thiopurine pharmacogenetics in leukemia: Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clinical Pharmacology & Therapeutics. 41(1). 18–25. 271 indexed citations

16.

Loon, Jon A. Van & R. M. Weinshilboum. (1987). Human lymphocyte thiopurine methyltransferase pharmacogenetics: effect of phenotype on 6-mercaptopurine-induced inhibition of mitogen stimulation.. Journal of Pharmacology and Experimental Therapeutics. 242(1). 21–26. 16 indexed citations

17.

Ames, Matthew M., Cynthia Dias Selassie, Lee C. Woodson, et al.. (1986). Thiopurine methyltransferase: structure-activity relationships for benzoic acid inhibitors and thiophenol substrates. Journal of Medicinal Chemistry. 29(3). 354–358. 39 indexed citations

18.

Loon, Jon A. Van, et al.. (1985). Human erythrocyte histamine N-methyltransferase: radiochemical microassay and biochemical properties. Clinica Chimica Acta. 149(2-3). 237–251. 21 indexed citations

19.

Young, William F., Charles F. Abboud, Edward R. Laws, Jon A. Van Loon, & Richard M. Weinshilboum. (1984). Erythrocyte Catechol-O-Methyltransferase, Platelet Monoamine Oxidase, and Platelet Phenol Sulfotransferase Activities in Patients with Prolactin Secreting Pituitary Adenomas*. The Journal of Clinical Endocrinology & Metabolism. 59(6). 1207–1210. 2 indexed citations

20.

Loon, Jon A. Van & Richard M. Weinshilboum. (1982). Thiopurine methyltransferase biochemical genetics: Human lymphocyte activity. Biochemical Genetics. 20(7-8). 637–658. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact